Literature DB >> 32277949

The Fate of Plasma Exchange and Glucocorticoid Dosing in ANCA-Associated Vasculitis After PEXIVAS.

Frank B Cortazar1, John L Niles2.   

Abstract

Entities:  

Year:  2020        PMID： 32277949     DOI： 10.1053/j.ajkd.2020.03.010

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN： 0272-6386            Impact factor:   8.860


× No keyword cloud information.
  4 in total

1.  PEXIVAS: The End of Plasmapheresis for ANCA-Associated Vasculitis?

Authors:  An S De Vriese; Fernando C Fervenza
Journal:  Clin J Am Soc Nephrol       Date:  2020-09-22       Impact factor: 8.237

Review 2.  Is There Still a Role of Plasma Exchange in the Current Management of ANCA-Associated Vasculitides?

Authors:  Task Toyoda; Max Yates; Richard A Watts
Journal:  Curr Rheumatol Rep       Date:  2022-03-22       Impact factor: 4.592

3.  Successful hemostasis in refractory alveolar hemorrhage using low-dose recombinant activated factor VII.

Authors:  John Selickman; Jacob Fiocchi; Hem Desai; Kathryn M Pendleton
Journal:  Respir Med Case Rep       Date:  2022-09-16

4.  Consideration of Therapeutic Plasma Exchange in Association With Inflammatory Lesions in ANCA-Associated Glomerulonephritis: A Real-World Retrospective Study From a Single Center.

Authors:  Désirée Tampe; Philipp Ströbel; Peter Korsten; Samy Hakroush; Björn Tampe
Journal:  Front Immunol       Date:  2021-06-17       Impact factor: 7.561
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.